Editorial comment--Thromboembolic events during neuroendovascular procedures.
Qureshi
Adnan I
AI
D000783:Aneurysm / Q000601:surgery; D001777:Blood Coagulation / Q000187:drug effects; D004621:Embolization, Therapeutic / Q000009:adverse effects; D006801:Humans; D007269:Injections, Intra-Arterial; D019635:Neurosurgical Procedures / Q000009:adverse effects*; D010960:Plasminogen Activators / Q000008:administration & dosage; D019736:Prostheses and Implants / Q000009:adverse effects; D015607:Stents / Q000009:adverse effects; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator